Analyst ratings, especially downgrades, can significantly influence investor sentiment and stock price in the short term. The downgrade from Buy to Neutral suggests a less optimistic outlook on Sharecare's future performance, which could lead to a decrease in investor confidence and a potential drop in stock price.